Introduction
Cardiovascular disease is a leading cause of morbidity and mortality in developed countries, and the incidence of death from cardiovascular causes, up until recently, was rising.
1,2 Many patients do not experience symptoms before a first major cardiovascular event such as a sudden cardiac arrest, myocardial infarction or arrhythmia. 3 An important contributory factor appears to be the failure to detect these cardiac disorders until late in their natural history, thus missing the therapeutic window where maximum benefit could be offered with timely intervention. Assessment of traditional risk factors such as age, sex, blood pressure, diabetes mellitus (DM) and cigarette smoking can help predict cardiovascular disease, but do not identify all those at risk. 4 The resting electrocardiogram (ECG) is one of the most common diagnostic tests in routine clinical practice, and minor or major abnormalities have been shown to be independently associated with an increased incidence of cardiovascular disease and mortality from coronary artery disease. 5 Given its low cost, wide use and safety, the resting 12-lead ECG may help identify asymptomatic individuals with a high risk of cardiovascular disease and help better guide the use of risk reduction therapies. 6 We undertook a prospective Registry Study to assess the prevalence of ECG abnormalities and their relation to hypertension and other cardiovascular risk factors in an apparently healthy population of subjects living in the relatively affluent South East of England.
Materials and methods
A clinical screening survey was conducted on 4739 consecutive apparently healthy individuals between March 2009 and March 2013. Subjects were invited by their General Practitioner using a standard letter outlining the survey to participate and agreed to the screening. All subjects completed a medical questionnaire, which included use of anti-hypertensive and anti-hypercholestrolaemic medications. Subjects underwent measurement of their weight and height, and a blood sample was taken for measurement of random serum cholesterol. A nurse measured sitting blood pressure and heart rate after 5 min of rest. A resting electrocardiogram (ECG) was then performed.
Statistical methods
Results are expressed as mean 6 standard deviation, absolute numbers (n) and frequencies (%). Strength of association between baseline characteristics and ECG abnormalities was determined by calculation of Spearman correlation coefficients, and multi-variate logistic regression analysis. The chi-squared (X 2 ) test was used to compare frequencies of ECG abnormalities in males and females. A P 0.05 was considered statistically significant. Data were analysed using SPSS version 21.
Ethical approval
All subjects gave informed consent prior to data collection for their anonymized clinical data to be recorded. As a Registry report using clinically collected, non-identifiable data, this work does not fall under the remit of National Health Service Research Ethics Committees. 
Results

Atrial fibrillation
Multi-variate analysis demonstrates that AF is significantly associated with increasing age (
0.07, P < 0.01) were all predictors of AF. Male gender was more strongly associated with AF than female gender (21 vs. 8; X 2 ¼ 8.04, P < 0.01). No significant associations were found between AF and blood pressure, body mass index (BMI), waist circumference, smoking or a history of angina.
Left bundle branch block
Multi-variate analysis showed that LBBB is significantly associated with increasing age (F ¼ 0.07, P ¼ 0.01), and reported history of angina (F ¼ 0.05, P ¼ 0.01) and regression analysis demonstrated both age (R 2 ¼ 0.07, P < 0.01) and angina (R 2 ¼ 0.08, P < 0.01) were predictors of LBBB. No significant relationships were found between LBBB and gender, blood pressure, BMI, waist circumference, DM, cholesterol or smoking.
Right bundle branch block
Multi-variate analysis showed that RBBB is significantly associated with increasing age (F ¼ 0.86, P ¼ 0.01), DM (F ¼ 0.04, P ¼ 0.01) and a greater waist circumference (F ¼ 0.04, P ¼ 0.05) and with male gender (F ¼ -0.62, P ¼ 0.01) and serum cholesterol (F ¼ -0.03, 
Left ventricular hypertrophy
Multi-variate analysis showed that LVH is significantly associated with systolic (F ¼ 0.12, P ¼ 0.01) and diastolic blood pressure (F ¼ 0.99, P ¼ 0.01) and with male gender (F ¼ -0.11, P ¼ 0.01) and BMI (F ¼ -0.69, P ¼ 0.01). Regression analysis showed that gender (R 2 ¼ 0. 
First-degree heart block
Multi-variate analysis showed that first-degree HB is significantly associated with increasing age (F ¼ 0.097, P < 0.01), BMI (F ¼ 0.05, P < 0.01) and waist circumference (F ¼ 0.047, P ¼ 0.001). While regression analysis confirmed that age (R 2 ¼ 0.009, P < 0.01), BMI (R 2 ¼ 0.02, P < 0.01) and waist circumference (R 2 ¼ 0.02, P < 0.01) were all independent predictors of first-degree HB.
Male gender was more strongly associated with first-degree HB than female gender (77 vs. 59; X 2 ¼ 6.06, P ¼ 0.01). No significant relationships were found between first-degree HB and smoking, angina, serum cholesterol or DM.
Discussion
Our findings demonstrate that resting 12-lead ECG abnormalities are relatively common in asymptomatic individuals, affecting almost one third (31.8%) of our study population, with LVH being the most prevalent abnormality, followed by first-degree HB and RBBB. Abnormal ECG findings were associated with an increasing age, higher blood pressure, greater waist circumference and lower serum cholesterol. All the ECG abnormalities analysed were independently associated with an increase in age, except for LVH. DM was associated with RBBB and AF, and only LBBB was associated with a reported history of angina. Interestingly lower serum cholesterol was associated with abnormal ECG findings, and independently with AF. This was an unexpected finding, given that raised serum cholesterol is a risk factor for cardiovascular disease. 8 However previous population studies have shown this increased risk has not translated to an increased prevalence of ECG abnormalities. 5 Considering that one fifth of participants in this survey were on anti-hypercholesterolaemic medication, an explanation may be that these patients had already been identified as being at a higher cardiovascular risk and therefore had modified their diet/lifestyle or started cholesterol-lowering medications. We suggest that those with lower serum cholesterol should also be included in ECG screening programs, as it does not exclude the possibility of an abnormal ECG and serum cholesterol should not be used in isolation when assessing cardiovascular risk. LVH was the most prevalent ECG abnormality, and was associated with an increased systolic and diastolic blood pressure. This is consistent with previous population studies, which demonstrated that electrocardiographic evidence of LVH is associated with increased cardiovascular morbidity and mortality. 9 Furthermore persistent LVH ECG patterns are associated with left ventricular systolic dysfunction and subsequent heart failure. 10 Our study demonstrated an inverse relationship between LVH ECG patterns and BMI, despite previous studies demonstrating an association between LVH and obesity. Obesity reduces the sensitivity of LVH diagnosis on ECG, due to adipose tissue interfering with the ECG voltage tracing and masking the LVH pattern. The relationship shown in our study is more likely to represent the inaccuracy of ECG tracings seen when evaluating LVH in obese subjects. Furthermore other conditions such as co-existent ischaemic heart disease may interfere with surface potentials and mask LVH. Therefore ECG should not be used as a surrogate for echocardiogram, which remains the main standard in diagnosing LVH.
11
First-degree HB was the second most common ECG abnormality and was strongly associated with increasing age and male gender. 12 It was previously considered a benign arrhythmia, but recently a prolonged P-R interval has been linked with an increased left ventricular mass indexed to body surface area, due to an increased ventricular wall thickness. A delay in atrioventricular conduction can lead to diastolic mitral valve regurgitation and although this is inconsequential in a normal heart, it appears significant in those with left ventricular dysfunction. 13 With an aging population, the prevalence of first-degree HB is likely to increase and become more important, even in those not experiencing symptoms.
RBBB was the third most common abnormality identified, and there is debate as to whether it carries a negative prognosis. The Copenhagen City Heart Study 14 acknowledged an increasing prevalence of RBBB with age and an association with male gender. RBBB was associated with a greater risk of myocardial infarction, arrhythmias requiring pacemaker insertion, increased cardiovascular risk and all-cause mortality. 14 This was supported by a prospective observational study that analysed 583 subjects with RBBB and demonstrated an association with male gender, DM and coronary artery disease. Over 80% of subjects had at least one conventional cardiovascular risk factor. Subsequent angiography demonstrated coronary artery disease in over 90% of patients, with triple vessel disease in nearly half of the patients. The left anterior descending artery was most commonly involved. 15 RBBB carries an increased risk of mortality, which is significantly greater in those with underlying cardiovascular disease or risk factors. In patients with left ventricular dysfunction, RBBB is associated with increased mortality compared to those with a normal QRS morphology and even those with LBBB; and this risk becomes more pronounced as the ejection fraction decreases. It is thought that RBBB may act as a surrogate for pulmonary hypertension and right ventricular failure, and in those with underlying left ventricular dysfunction it may represent biventricular failure, and hence carry a worse prognosis. 16 These findings were echoed in a large meta-analysis of observational studies, which concluded that RBBB carried an increased risk of all cause mortality and cardiovascular death in the general population and heart failure patients. 17 Therefore although it was previously reported that RBBB was a benign entity, it does carry a significant risk of mortality, which appears to be worse in those with underlying cardiovascular disease. Our study demonstrated that LBBB was associated with increasing age, and angina. This is in keeping with previous epidemiological studies that have reported an association with coronary artery disease and dilated cardiomyopathy. These studies also did not show any association between LBBB and gender, cholesterol, smoking and BMI, however in contrast to our study LBBB was associated with hypertension. 18, 19 LBBB carries a poor prognosis and is a predictor of mortality, even in those who are asymptomatic. In men with no known history of stroke or myocardial infarction, LBBB was associated with a 4-fold increased risk of death from coronary artery disease, 18-fold risk of atrioventricular block and a 12-fold risk of requiring a pacemaker. 19 In women with underlying coronary artery disease, both LBBB and RBBB were predictors of all-cause mortality, but only LBBB was predicative of cardiovascular death, while in women free of cardiovascular disease LBBB remained a predictor of cardiovascular death. 20 These findings are supported by a recent cohort study of asymptomatic patients, free of underlying cardiovascular disease, which demonstrated that LBBB carried a 3-fold increased risk of heart failure and 4-fold increased risk of mortality (both of which remained significant after controlling for confounding factors). 21 The development of LBBB has been associated with LVH, and carries a significant risk of sudden death even in those without prior cardiovascular symptoms. The combination of both entities carries a profoundly higher risk of all-cause mortality and cardiovascular mortality. In hypertensive patients with evidence of LVH, LBBB identifies those at increased risk of cardiovascular mortality, sudden cardiovascular death and heart failure. 22 The general consensus is that LBBB is a pathological phenomenon, which carries a significant risk of mortality and this risk is increased further by the presence of underlying cardiovascular disease. It is also an independent predictor of subsequent coronary artery disease, LVH and congestive cardiac failure; all of which worsen these patients' outcomes.
Our data are in agreement with previous reports showing that AF is associated with increasing age, male gender, DM and lower serum cholesterol. The paradoxical association between serum cholesterol and AF has been previously reported, and is thought to be due to the membrane-stabilizing characteristics of cholesterol although the exact pathophysiology remains unclear. [23] [24] [25] AF is the most common type of serious arrhythmia, occurring in 1-2% of the population and the incidence doubles with each decade after 50 years of age, approaching 15% in those over the age of 80 years. AF is a major cause for stroke, cognitive dysfunction, heart failure and mortality. 23, 24 Along with increasing age, comes an increasing prevalence of disease and increasing risk of complications. Irrespective of its underlying aetiology, AF carries a 5-7 fold higher risk of stroke than sinus rhythm. Early identification and treatment through anti-coagulation can vastly reduce this risk and significantly improve outcomes. 26 A large review of 63 prospective studies concluded that ECG abnormalities were associated with increased risk of subsequent cardiovascular events, even after adjusting for traditional risk factors (pooled hazard ratio estimates from 1.4-2.1). 27 However a retrospective study found that as many as 38.5% of general practitioner referrals to a cardiologist were made without an ECG being performed in primary care. 28 Furthermore a cohort study in primary care found that only 7.2% of patients followed up over 7.8 years had an ECG, even though a significant proportion of patients were deemed to have an intermediate or high cardiovascular risk (9.7% and 9.3%, respectively). 29 
Limitations
This survey was based in the South East of England and contained a predominantly affluent Caucasian cohort. Therefore we are unable to comment on whether the same prevalence of ECG abnormalities would be seen in wider areas of the UK, especially those inhabited by a greater proportion of ethnic minorities. Furthermore the patients were not followed up and therefore we are unable to comment on whether identification of the above ECG abnormalities had an effect on treatment and outcomes. Confirmation of our results in a larger multi-centre trial with a potential follow up period would be appropriate.
Conclusions
The present registry study demonstrates that middle-aged men and women in the UK with no overt cardiac symptoms may be at significant risk of having a cardiac conduction abnormality with potentially serious future complications. ECG offers the potential to identify these abnormalities and provide earlier intervention and treatment and possibly improve cardiovascular outcome. In view of the ready availability at a population level of this non-invasive, low cost investigation, ECG is well placed to be included in future preventive strategies for early detection of sub-clinical abnormalities.
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